ABCD2 — ATP Binding Cassette Subfamily D Member 2

ABCD2 — ATP Binding Cassette Subfamily D Member 2

Gene Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#4477AA; color:white; text-align:center">ABCD2</th></tr>
<tr><th>Full Name</th><td>ATP Binding Cassette Subfamily D Member 2</td></tr>
<tr><th>Chromosome</th><td>12q12</td></tr>
<tr><th>NCBI Gene ID</th><td>[225](https://www.ncbi.nlm.nih.gov/gene/225)</td></tr>
<tr><th>OMIM</th><td>[601081](https://www.omim.org/entry/601081)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000173208</td></tr>
<tr><th>UniProt ID</th><td>[Q9H0H5](https://www.uniprot.org/uniprot/Q9H0H5)</td></tr>
<tr><th>Associated Diseases</th><td>X-linked Adrenoleukodystrophy, Zellweger Spectrum, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Introduction

ABCD2 (ATP Binding Cassette Subfamily D Member 2) is a peroxisomal ATP-binding cassette transporter primarily involved in the import of very long-chain fatty acids (VLCFAs) and branched-chain fatty acids into peroxisomes for beta-oxidation[@berger2019]. As a member of the ALD subfamily (along with ABCD1 and ABCD3), ABCD2 plays a critical role in maintaining lipid homeostasis, particularly in the brain where peroxisomes are essential for myelin maintenance and neuronal function[@ferrer2005].

ABCD2 — ATP Binding Cassette Subfamily D Member 2

Gene Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#4477AA; color:white; text-align:center">ABCD2</th></tr>
<tr><th>Full Name</th><td>ATP Binding Cassette Subfamily D Member 2</td></tr>
<tr><th>Chromosome</th><td>12q12</td></tr>
<tr><th>NCBI Gene ID</th><td>[225](https://www.ncbi.nlm.nih.gov/gene/225)</td></tr>
<tr><th>OMIM</th><td>[601081](https://www.omim.org/entry/601081)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000173208</td></tr>
<tr><th>UniProt ID</th><td>[Q9H0H5](https://www.uniprot.org/uniprot/Q9H0H5)</td></tr>
<tr><th>Associated Diseases</th><td>X-linked Adrenoleukodystrophy, Zellweger Spectrum, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Introduction

ABCD2 (ATP Binding Cassette Subfamily D Member 2) is a peroxisomal ATP-binding cassette transporter primarily involved in the import of very long-chain fatty acids (VLCFAs) and branched-chain fatty acids into peroxisomes for beta-oxidation[@berger2019]. As a member of the ALD subfamily (along with ABCD1 and ABCD3), ABCD2 plays a critical role in maintaining lipid homeostasis, particularly in the brain where peroxisomes are essential for myelin maintenance and neuronal function[@ferrer2005].

Research over the past decade has revealed that ABCD2 dysfunction extends beyond peroxisomal disorders like X-linked adrenoleukodystrophy (X-ALD) to encompass broader neurodegenerative mechanisms, including those involved in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)[@ito2020; @kou2021]. The gene is particularly important in [oligodendrocytes](/cell-types/oligodendrocytes), the myelin-producing cells of the central nervous system, where it supports the high metabolic demand of myelin lipid synthesis[@sharer2021].

Gene Structure and Protein Architecture

The ABCD2 gene is located on chromosome 12q12 and encodes a 706-amino acid peroxisomal membrane protein. Like other ABC subfamily D members, ABCD2 functions as a half-transporter that requires dimerization with partner molecules (typically ABCD1) to form a functional heterodimeric transporter[@kemp2011].

Protein Domains

The ABCD2 protein contains several key structural features:

The protein's topology places both the NBDs in the cytosol, where they interact with the ATPase subunits to drive conformational changes that transport substrates across the peroxisomal membrane[@van2019].

Normal Biological Function

Peroxisomal VLCFA Import

ABCD2's primary function is the peroxisomal import of very long-chain fatty acids (VLCFAs, C24-C30)[@ferrer2005]:

• Substrate specificity: Transports CoA-activated VLCFAs including hexacosanoic acid (C26:0) and lignoceric acid (C24:0)
• Physiological importance: VLCFAs are essential components of myelin lipids (approximately 30% of myelin lipid mass)
• Beta-oxidation: Imported VLCFAs undergo peroxisomal beta-oxidation to generate medium-chain acetyl-CoA

Redundant and Compensatory Functions

ABCD2 has significant functional overlap with ABCD1:

• Partial compensation: ABCD2 can partially compensate for ABCD1 deficiency, which explains why complete loss of ABCD1 alone does not always cause severe disease
• Therapeutic implications: Upregulating ABCD2 expression has been explored as a strategy for X-ALD treatment[@kemp2011]
• Tissue-specific roles: ABCD2 expression is highest in brain white matter, liver, and adrenal glands

Role in Lipid Homeostasis

Beyond VLCFA metabolism, ABCD2 participates in[@correia2017]:

• Branched-chain fatty acid metabolism: Handles pristanic acid and other branched-chain FAs from dietary sources
• Bile acid synthesis: Transports intermediates in the peroxisomal portion of bile acid biosynthesis
• Ether phospholipid synthesis: Supports plasmalogen synthesis essential for myelin structure

Expression Pattern

ABCD2 exhibits tissue-specific expression with particular importance in neural tissues[@ferrer2005]:

Brain Expression

• Oligodendrocytes: Highest expression—these myelin-producing cells require robust VLCFA metabolism
• [Astrocytes](/entities/astrocytes): Moderate expression for lipid homeostasis
• Neurons: Lower expression but essential for axonal maintenance
• [Microglia](/cell-types/microglial-neuroinflammation): Emerging evidence for role in neuroinflammation[@yamada2021]

Regional Distribution

• White matter: Highest expression in cerebral white matter
• Hippocampus: Notable expression in [hippocampus](/brain-regions/hippocampus) pyramidal neurons
• Substantia nigra: Present in dopaminergic neurons—relevant to Parkinson's disease
• Cerebellum: Purkinje cells show significant expression

Disease Associations

X-Linked Adrenoleukodystrophy (X-ALD)

While X-ALD is primarily caused by ABCD1 mutations, ABCD2 modifies disease severity[@weinhofer2022]:

• Modifier gene: ABCD2 polymorphisms influence phenotype variation in X-ALD
• Therapeutic target: Pharmacological upregulation of ABCD2 can partially compensate for ABCD1 deficiency[@kemp2011]
• Female carriers: ABCD2 expression provides protection in heterozygous females
• Adrenomyelopathy: ABCD2 dysfunction contributes to adult-onset spinal cord disease

Alzheimer's Disease

ABCD2 dysfunction contributes to AD pathogenesis through multiple mechanisms[@ito2020; @liu2022]:

Parkinson's Disease

ABCD2 plays a role in PD through[@kou2021; @ruiz2023]:

• Dopaminergic neuron vulnerability: Substantia nigra neurons have high peroxisomal activity; ABCD2 deficiency increases their susceptibility to stress
• Lipid metabolism alterations: PD brains show altered VLCFA ratios similar to those seen in peroxisomal disorders
• Mitochondrial interaction: Peroxisomes and mitochondria cooperate in lipid metabolism; dysfunction in one affects the other

Other Neurodegenerative Conditions

• Zellweger spectrum disorders: ABCD2 mutations can contribute to peroxisome biogenesis disorders
• Amyotrophic lateral sclerosis (ALS): Peroxisomal dysfunction observed in ALS models
• Multiple sclerosis: Myelin maintenance depends on ABCD2 function
• Aging-related neurodegeneration: Age-related decline in peroxisomal function is exacerbated by ABCD2 reduction[@petrangelo2019]

Molecular Mechanisms

Peroxisome-Neuronal Interactions

Therapeutic Implications

Several therapeutic strategies targeting ABCD2 are under investigation[@trotter2020]:

| Approach | Status | Mechanism |
|----------|--------|-----------|
| PPAR agonists | Preclinical | Upregulate ABCD2 expression |
| Gene therapy | Research | AAV-mediated ABCD2 delivery |
| Small molecule modulators | Research | Increase ABCD2 transporter activity |
| Cell therapy | Research | Transplant ABCD2-competent cells |

Key Research Findings

2019-2024 Landmark Studies

Animal Models

Several mouse models have been developed to study ABCD2 function:

• ABCD2 knockout mice: Show subtle VLCFA elevation but minimal phenotype under normal conditions
• ABCD1/ABCD2 double knockout: Develop severe VLCFA accumulation and neurological dysfunction
• Conditional knockout models: Oligodendrocyte-specific ABCD2 deletion causes myelin abnormalities

Interaction Network

ABCD2 interacts with several key proteins and pathways[@marchetti2022]:

• ABCD1: Forms functional heterodimers
• PEX19: Peroxisomal membrane targeting
• PEX3: Peroxisome biogenesis
• ACOX1: First enzyme in peroxisomal beta-oxidation
• MFP1/2: Bifunctional enzyme in beta-oxidation

See Also

• [X-Linked Adrenoleukodystrophy](/diseases/x-linked-adrenoleukodystrophy)
• [Peroxisomes](/entities/peroxisomes)
• [Very Long-Chain Fatty Acids](/entities/vlcfa)
• [Myelin](/entities/myelin)
• [Oligodendrocytes](/cell-types/oligodendrocytes)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene: ABCD2](https://www.ncbi.nlm.nih.gov/gene/225)
• [UniProt: Q9H0H5](https://www.uniprot.org/uniprot/Q9H0H5)
• [Ensembl: ENSG00000173208](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000173208)
• [OMIM: 601081](https://www.omim.org/entry/601081)
• [GeneCards: ABCD2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ABCD2)

Brain Atlas Resources

• [Allen Human Brain Atlas](https://human.brain-map.org/) — gene expression data
• [BrainSpan Atlas](https://brainspan.org/) — developmental transcriptome
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — mouse brain gene expression

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ABCD2 — ATP Binding Cassette Subfamily D Member 2 discovered through SciDEX knowledge graph analysis: